Market Focus Coppe Labs serves academic medical centers, children's hospitals, infertility clinics, and integrative healthcare providers nationwide, creating strong outbound opportunities for virology CRO partnerships. Emphasize comprehensive viral diagnostics and contract research delivered with BSL-2/3 capabilities to institutions seeking outsourced lab services.

Containment Advantage High containment capabilities including BSL3 for SARS-CoV-2 and Powassan virus and BSL2 for HHV-6A/B, EBV, CMV, and HHV-7 distinguish Coppe Labs as a preferred partner for vaccine, antiviral, and surveillance programs. Target pharma, biotech, government, and academic consortia needing safe handling and compliant workflows.

Clinical Diagnostics Clinically oriented tests such as ci-HHV-6 and HHV-6 IHC, plus Powassan virus testing, position Coppe as a provider of end-to-end viral diagnostics and bespoke assay development. Opportunities to upsell to hospitals and clinics with expanded panels and integrated reporting.

Growth Agility As a small, nimble lab with focused capabilities, Coppe can offer pilot collaborations, fast-turnaround projects, and milestone-based pricing to mid-sized institutions and research groups seeking personalized service from a CRO partner.

Digital Readiness With a modern tech stack and digital intake tools, Coppe can enable secure data transfer, reporting, and client portals for academic and healthcare clients, presenting a value-add over larger, less flexible CROs. Potential to co-market leveraging their online presence and data capabilities.